Does NIRAPARIB Cause Product dose omission? 332 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 332 reports of Product dose omission have been filed in association with NIRAPARIB (ZEJULA). This represents 1.5% of all adverse event reports for NIRAPARIB.
332
Reports of Product dose omission with NIRAPARIB
1.5%
of all NIRAPARIB reports
9
Deaths
101
Hospitalizations
How Dangerous Is Product dose omission From NIRAPARIB?
Of the 332 reports, 9 (2.7%) resulted in death, 101 (30.4%) required hospitalization, and 22 (6.6%) were considered life-threatening.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 332 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which NIRAPARIB Alternatives Have Lower Product dose omission Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP